Boric acid topical Pregnancy and Breastfeeding Warnings
Brand names: Borofax, Hylafem
Boric acid topical Pregnancy Warnings
Use is contraindicated.
US FDA pregnancy category: Not assigned
Comments:
-There is no data on use in pregnant women to know this drugs risks, including the risk of fetal harm or reproductive effects.
Animal studies are not available. There are no controlled data in human pregnancy.
US FDA pregnancy category Not Assigned: The US FDA has amended the pregnancy labeling rule for prescription drug products to require labeling that includes a summary of risk, a discussion of the data supporting that summary, and relevant information to help health care providers make prescribing decisions and counsel women about the use of drugs during pregnancy. Pregnancy categories A, B, C, D, and X are being phased out.
Boric acid topical Breastfeeding Warnings
Use is contraindicated.
Excreted into human milk: Data not available
Excreted into animal milk: Data not available
Comments:
-There is no information regarding this drug on the presence in human milk, the effects on a breastfed infant, or effects on milk production.
References for pregnancy information
- Product Information. Boric Acid (boric acid topical). Fougera. 2001.
- Product Information. Hylafem (boric acid topical). US Pharmaceutical Corporation. 2019.
References for breastfeeding information
- Product Information. Boric Acid (boric acid topical). Fougera. 2001.
- Product Information. Hylafem (boric acid topical). US Pharmaceutical Corporation. 2019.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.